NBTX (Nanobiotix) Research & Development: $26.81 Mil (TTM As of Dec. 2025)


NBTX Nanobiotix SA NBTX
24 GF Score
Price $35.99
! 3 Warning Signs
View Full Analysis

What is Nanobiotix Research & Development?

Nanobiotix NBTX +5.67% 24 Research & Development is $26.81 Mil as of Dec. 2025. GuruFocus rates NBTX with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nanobiotix's Research & Development for the six months ended in Dec. 2025 was $10.05 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $26.81 Mil.

Nanobiotix  (NAS:NBTX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nanobiotix Research & Development Related Terms

Nanobiotix Research & Development Historical Data

* Premium members only.

The historical data trend for Nanobiotix's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nanobiotix Research & Development Chart

Nanobiotix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.33 34.57 41.87 42.45 27.07

Nanobiotix Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.46 23.67 19.43 16.76 10.05
NBTX
24GF Score
Nanobiotix SA NBTX
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nanobiotix Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $26.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $26.81 Mil mean?
Nanobiotix (NBTX) has a Research & Development of $26.81 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nanobiotix and its competitors.
Is Nanobiotix's Research & Development too high?
Nanobiotix's current Research & Development is $26.81 Mil. Overall, Nanobiotix has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Nanobiotix's Research & Development compare to VRTX and REGN?
Nanobiotix's Research & Development of $26.81 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nanobiotix and its competitors. Nanobiotix's current Research & Development is $26.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanobiotix stock overvalued right now?
Nanobiotix (NBTX) has a current Research & Development of $26.81 Mil. The current Research & Development is $26.81 Mil. Nanobiotix's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nanobiotix (NBTX), the current Research & Development is $26.81 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanobiotix Business Description

Address 60 Rue de Wattignies, Paris, FRA, 75012
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
24GF Score

Get the complete analysis for NBTX

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$35.99
Price